HCANF - Halo Collective's subsidiary Bophelo closes first sale of cannabis flower

Halo Collective's (HCANF) wholly-owned subsidiary Bophelo Bioscience & Wellness completed its first sale of cannabis flower to a licensed cannabis producer and exporter based in Lesotho, Africa.The license-to-license market in Africa is estimated to be $7.1B by 2023 and Bophelo is uniquely positioned to capitalize by cultivating high quality flower at affordable prices for African patients."As Bophelo begin sales in Africa and soon in Europe, Halo believe that our sales from Bophelo could exceed our sales in California within months and Oregon within a year. This initial sale, with potential revenue of over six times Bophelo's estimated cultivation costs, leads Halo to believe that Bophelo can become profitable in 2021," founder & Head of International Operations Andreas Met commented.

For further details see:

Halo Collective's subsidiary Bophelo closes first sale of cannabis flower